Pliant Therapeutics Inc Sustainability Reports
Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel integrin-based therapies for the treatment of fibrotic diseases and solid tumors. The company leverages its proprietary product discovery engine to develop tissue-specific integrin modulators.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493002Q5LITR7VHZH02
FIGI: BBG00C8083P2
3 reports from 2020 to 2024
